EyePoint Pharmaceuticals

SEC Filings

Form Description Filing date View
8-K

Report of unscheduled material events or corporate event

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
10-KT

Annual transition reports filed rule 13a-10 or 15d-10 of the Securities Exchange Act

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
8-K

Report of unscheduled material events or corporate event

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
5

Annual filing director officer or owner of more than ten percent.

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
EyePoint Pharmaceuticals